Patents by Inventor Laura Nielsen

Laura Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diamide macrocycles that are FXIa inhibitors
    Patent number: 10081623
    Abstract: The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: September 25, 2018
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jun Shi, William R. Ewing, Laura Nielsen, Zilun Hu, Mimi L. Quan
  • CONJUGATED POLYMER BLENDS FOR HIGH EFFICIENCY ORGANIC SOLAR CELLS
    Publication number: 20170331046
    Abstract: The invention relates to a process for producing a conjugated polymer blend. The process for producing the conjugated polymer blend comprises the mixture of: a polymer A (X-Y), where X is and Y is and h is a substituent, a polymer B (X-Y?) where X is Y? is and j is a substituent, and an acceptor. In this process h and j are different substituents and independently selected from each other.
    Type: Application
    Filed: May 11, 2017
    Publication date: November 16, 2017
    Applicant: PHILLIPS 66 COMPANY
    Inventors: Kathy Woody, Brian Worfolk, Laura Nielsen
  • DIAMIDE MACROCYCLES THAT ARE FXIA INHIBITORS
    Publication number: 20170283403
    Abstract: The present invention provides compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: September 3, 2015
    Publication date: October 5, 2017
    Inventors: Jun Shi, William R. Ewing, Laura Nielsen, Zilun HU, Mimi L. Quan